X3 News https://www.x3news.com/ X3 News RSS bg-bg Monbat AD https://www.x3news.com/displayNovina.jsp?formid=201765 Invitation and materials for a General shareholders meeting Fri, 11 Sep 2026 17:26:31 +03:00 Eurohold Bulgaria AD https://www.x3news.com/displayNovina.jsp?formid=201764 Invitation and materials for a General shareholders meeting Fri, 11 Sep 2026 17:21:52 +03:00 Sopharma AD https://www.x3news.com/displayNovina.jsp?formid=201761 Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014 Fri, 11 Sep 2026 16:24:15 +03:00 Sopharma AD https://www.x3news.com/displayNovina.jsp?formid=201760 Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014 Fri, 11 Sep 2026 16:07:45 +03:00 Sopharma AD https://www.x3news.com/displayNovina.jsp?formid=201759 Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014 Fri, 11 Sep 2026 15:45:47 +03:00 Sopharma AD https://www.x3news.com/displayNovina.jsp?formid=201756 Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014 Fri, 11 Sep 2026 15:18:14 +03:00 Sopharma AD https://www.x3news.com/displayNovina.jsp?formid=201754 Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014 Fri, 11 Sep 2026 13:51:36 +03:00 Sopharma AD https://www.x3news.com/displayNovina.jsp?formid=201753 Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014 Fri, 11 Sep 2026 13:26:23 +03:00 Sopharma AD https://www.x3news.com/displayNovina.jsp?formid=201752 Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014 Fri, 11 Sep 2026 13:00:34 +03:00 Sopharma AD https://www.x3news.com/displayNovina.jsp?formid=201751 Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014 Fri, 11 Sep 2026 11:24:52 +03:00 Sopharma AD https://www.x3news.com/displayNovina.jsp?formid=201750 Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014 Fri, 11 Sep 2026 11:16:22 +03:00 Sopharma AD https://www.x3news.com/displayNovina.jsp?formid=201749 Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014 Fri, 11 Sep 2026 11:08:54 +03:00 Sopharma AD https://www.x3news.com/displayNovina.jsp?formid=201748 Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014 Fri, 11 Sep 2026 10:54:40 +03:00 Sopharma AD https://www.x3news.com/displayNovina.jsp?formid=201736 Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014 Thu, 10 Sep 2026 15:53:49 +03:00 CB First Investment Bank AD https://www.x3news.com/displayNovina.jsp?formid=201734 Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014 Thu, 10 Sep 2026 15:33:14 +03:00 Sopharma AD https://www.x3news.com/displayNovina.jsp?formid=201732 Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014 Thu, 10 Sep 2026 15:22:30 +03:00 Sopharma AD https://www.x3news.com/displayNovina.jsp?formid=201731 Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014 Thu, 10 Sep 2026 14:52:25 +03:00 Eurohold Bulgaria AD https://www.x3news.com/displayNovina.jsp?formid=201728 Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014 Thu, 10 Sep 2026 14:18:37 +03:00 Sopharma AD https://www.x3news.com/displayNovina.jsp?formid=201727 Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014 Thu, 10 Sep 2026 14:07:46 +03:00 Sopharma AD https://www.x3news.com/displayNovina.jsp?formid=201725 Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014 Thu, 10 Sep 2026 13:43:52 +03:00 Sopharma AD https://www.x3news.com/displayNovina.jsp?formid=201719 Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014 Thu, 10 Sep 2026 10:23:07 +03:00 Sopharma AD https://www.x3news.com/displayNovina.jsp?formid=201716 Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014 Wed, 09 Sep 2026 15:23:28 +03:00 Sopharma AD https://www.x3news.com/displayNovina.jsp?formid=201710 Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014 Wed, 09 Sep 2026 13:36:49 +03:00 Sopharma AD https://www.x3news.com/displayNovina.jsp?formid=201709 Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014 Wed, 09 Sep 2026 13:08:46 +03:00 Sopharma AD https://www.x3news.com/displayNovina.jsp?formid=201701 Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014 Wed, 09 Sep 2026 11:20:16 +03:00 Sopharma AD https://www.x3news.com/displayNovina.jsp?formid=201684 Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014 Tue, 08 Sep 2026 15:29:23 +03:00 Sopharma AD https://www.x3news.com/displayNovina.jsp?formid=201681 Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014 Tue, 08 Sep 2026 13:54:41 +03:00 Sopharma AD https://www.x3news.com/displayNovina.jsp?formid=201680 Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014 Tue, 08 Sep 2026 13:24:43 +03:00